Abacavir, dolutegravir, and lamivudine and Lenvatinib
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Lenvatinib and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Lenvatinib Mesylate
- Abacavir, dolutegravir, and lamivudine-Lenvima
- Abacavir, dolutegravir, and lamivudine-Lenvima (14 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (18 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (20 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (24 MG Daily Dose)
- Lenvatinib-Abacavir, Lamivudine and Zidovudine Tablets
- Lenvatinib-Abacavir, lamivudine, and zidovudine
- Lenvatinib-Abaloparatide
- Lenvatinib-Abaloparatide Subcutaneous
- Lenvatinib-Abatacept
- Lenvatinib-Abatacept Auto-Injectors